(Q38055220)

27 August 2017

title

Tanshinone derivatives: a patent review (January 2006 - September 2012). (English)

1 reference

27 August 2017

Xiao-Hong Tian

1

1 reference

27 August 2017

Jian Hui Wu

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

25 October 2012

1 reference

Expert Opinion on Therapeutic Patents

27 August 2017

published in

1 reference

27 August 2017

volume

23

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

19-29

1 reference

Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbide dinitrate in treating angina pectoris? A systematic review of randomized controlled trials

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

New developments in the chemistry and biology of the bioactive constituents of Tanshen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Cardiovascular effects of Danshen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Low density lipoprotein oxidation and its pathobiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Superoxide production and expression of nox family proteins in human atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-κB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: protection against reactive oxygen and nitrogen species-induced cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA: a new activator of human cardiac KCNQ1/KCNE1 (I(Ks)) potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Neuroprotection of tanshinone IIA against cerebral ischemia/reperfusion injury through inhibition of macrophage migration inhibitory factor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

The neuroprotective effects of Tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA attenuates neuronal damage and the impairment of long-term potentiation induced by hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Neuroprotective capabilities of Tanshinone IIA against cerebral ischemia/reperfusion injury via anti-apoptotic pathway in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

The protective effects of tanshinone IIA on β-amyloid protein (1-42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

The protective effects of tanshinone IIA on neurotoxicity induced by β-amyloid protein through calpain and the p35/Cdk5 pathway in primary cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA protects PC12 cells from β-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Antiandrogenic, maspin induction, and antiprostate cancer activities of tanshinone IIA and its novel derivatives with modification in ring A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Clinical review 134: The endocrinology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Inhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Induction of apoptosis and inhibition of cell adhesive and invasive effects by tanshinone IIA in acute promyelocytic leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA triggers p53 responses and apoptosis by RNA polymerase II upon DNA minor groove binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Tanshinone IIA interacts with DNA by minor groove-binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Nitrogen-containing compounds from Salvia miltiorrhiza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Antitumor Agents. 239. Isolation, structure elucidation, total synthesis, and anti-breast cancer activity of neo-tanshinlactone from Salvia miltiorrhiza

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Antitumor agents. 254. Synthesis and biological evaluation of novel neo-tanshinlactone analogues as potent anti-breast cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.736494

Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/PMIC.200900178

10.1517/13543776.2013.736494

23 March 2024

Identifiers

DOI

1 reference

release_xs4prfwyprhqfmtxl7zvfyaj7u

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xs4prfwyprhqfmtxl7zvfyaj7u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference